| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |